Lupin signs MoU with Govt. of Maharashtra to combat rising prevalence of cardiovascular diseases
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
The partnership aims to prioritize the diagnosis and treatment of these diseases while working to reducing their long-term prevalence
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
Convergent action on AMR identified as an important area of intervention
The new range of HDPE bottles is compliant with US FDA, EU regulations and Chinese DMF registration for use in dry pharmaceutical applications
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests
The new lab will enable the Group to accelerate its efforts in this area, building new competencies and capabilities, as well as strengthening Solvay’s ability to develop breakthroughs in biodegradable-by-design solutions.
The EU certification will support supplies of drug products registered in Europe, from this manufacturing site
Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration
Subscribe To Our Newsletter & Stay Updated